# MaRI Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mari-co

- Industry: Medical Devices & Equipment
- Headquarters: Japan
- Website: www.marisleep.com
- Total disclosed funding: $7.3M
- Latest round: Series B (Dec 22, 2023)
- Investors on record: 5

## About

Based in Kyoto, Japan, and founded in 2017 by its CEO, Hirofumi Taki, MaRI Co., Ltd. operates as a developer of a non-contact medical device technology that monitors and treats sleep apnea. In January 2022, Global Brain, along with Kirin Holdings Company, Limited, invested in MaRI Co., Ltd.

MaRI Co., Ltd. develops a non-contact diagnostic and treatment device for treating sleep apnea syndrome. Its devices reduce the burden on patients by detecting and treating their sleep patterns in a completely contactless, non-invasive manner. The company's products include Vital Watcher, which uses mmWave Rader technology, and Bedside Snoring Stopper, which detects snoring sounds.

The investment will support MaRI Co., Ltd.'s business growth through the collaboration of Global Brain and Kirin Holdings Company, Limited.

## Funding rounds

- Series B, Dec 22, 2023, $2.4M — SMBC Venture Capital, Global Brain, MedVenture Partners, Kyoto University Innovation Capital, Kyoto Capital Partners
- Series A, Jan 20, 2022, $2.6M — Global Brain, MedVenture Partners, Kyoto University Innovation Capital
- Series A, Feb 27, 2020, $2.3M — MedVenture Partners

## Investors

- MedVenture Partners (https://capitalatlas.ai/funds/medventure-partners) — Series A, Series B
- Global Brain (https://capitalatlas.ai/funds/global-brain) — Series A, Series B
- Kyoto University Innovation Capital (https://capitalatlas.ai/funds/kyoto-university-innovation-capital) — Series A, Series B
- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Series B
- Kyoto Capital Partners (https://capitalatlas.ai/funds/kyoto-capital-partners) — Series B